Patent assignee · US · COMPANY

Kappa-Pharma LLC

2Patents
2Active
2Granted
44Portfolio score

Filing activity: Aug 14, 2019 → Jul 1, 2021

Most-cited patents

PatentTitleAreaCited byStatus
US11851439B2 Compositions and methods of use for opioid hexadienoates and optionally substituted hexadienoates Chemistry; Metallurgy 0 Active
US11186585B2 Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.